Drug

Who makes emtricitabine, rilpivirine, tenofovir disoproxil fumarate?

2 companies list emtricitabine, rilpivirine, tenofovir disoproxil fumarate as a human prescription drug. Forms: tablet, film coated. Routes: oral. Counted across 2 spellings of the name in the directory, such as “emtricitabine rilpivirine and tenofovir disoproxil fumarate”, “emtricitabine rilpivirine tenofovir disoproxil fumarate”.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing emtricitabine, rilpivirine, tenofovir disoproxil fumarate

CompanyFormsApplicationNDCsRegistered sites
LAURUS LABS LIMITEDIndiatablet, film coatedANDAANDA22023215
Mylan Pharmaceuticals, Inc.tablet, film coatedANDAANDA20845210
Enquiry

Common questions

Who makes emtricitabine, rilpivirine, tenofovir disoproxil fumarate?
2 companies list emtricitabine, rilpivirine, tenofovir disoproxil fumarate as a human prescription drug in the openFDA NDC Directory, led by LAURUS LABS LIMITED, Mylan Pharmaceuticals, Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Is there a generic emtricitabine, rilpivirine, tenofovir disoproxil fumarate?
2 companies list emtricitabine, rilpivirine, tenofovir disoproxil fumarate under an abbreviated new drug application (ANDA), the application type used for generics. Listing status is from the NDC Directory; it is not a statement of availability.